- Oops!Something went wrong.Please try again later.
Supported by solid fundamentals and anticipated future growth, a prominent retailer cranks its payout higher.
The last few years saw the markets go crazy. Between the COVID lockdowns and market crash, the rebound recovery, last year’s sustained bull run, and this year’s devastating first half that saw the bull turn into a bear. But in all of that, there have been stocks that have outperformed the market. These winning stocks have attracted attention from Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program. Among other things, Cramer has been following stocks which won big during the COVID cris
Persistent supply issues have deflated expectations for the Chinese automaker
Investors like getting a return on investment, of course, it’s why they are in the market to begin with. And when a company makes a commitment to return capital and profits to the shareholders, that’s a win – one that will both attract and reward investors. The key for investors is to find the best possible capital return, and dividend stocks make a logical place to start looking. With this in mind, we’ve used the TipRanks database to pull up the details on two true dividend aristocrats – real c
While every market advisor will tell you never to try to ‘time’ the market, timing is still important for success. Investors need to buy into low prices, and to do that, they need to know when prices are low. This doesn’t necessarily mean low in absolute dollar terms, but low relative to a stock’s recent past performance. In recognizing that lower price range, investors can turn to Wall Street’s pros for help. The analysts have been busy lately, picking out stocks that are in their lower price r
(Reuters) -Wednesday's consumer price index report showing U.S. inflation didn't accelerate in July was the first "positive" reading on price pressures since the Federal Reserve began tightening policy, Chicago Fed President Charles Evans said, even as he signaled he believes the Fed has plenty more work to do. With consumer prices unchanged last month compared to June, but up 8.5% from a year earlier, inflation is still "unacceptably" high, and the Fed will likely need to lift its policy rate, currently in the 2.25%-2.5% range, to 3.25%-3.5% this year and to 3.75%-4% by the end of next year, Evans said. The remarks suggest Evans, among the 19 central bankers who set U.S. monetary policy, expects to soon slow what's been the Fed's steepest round of interest-rate hikes in decades.
Value stocks in the S&P 500 are outperforming this year. But analysts still think it's a mistake to part with some of them too soon.
(Bloomberg) -- The cooler-than-expected US inflation reading for July is a positive sign that has buoyed risk assets, but some investors may be getting a little ahead of themselves, according to analysts.Most Read from BloombergMusk Sells Another $6.9 Billion of Tesla Ahead of Twitter TrialDozens in China Infected With New ‘Langya’ Virus Carried by ShrewsUS Inflation Runs Cooler Than Forecast, Easing Pressure on FedMedia Counts Differ With 10 Million Votes Counted: Kenya UpdateRussia Is Scouring
The Senior Citizens League projects the annual cost-of-living adjustment for 2023 to come in at 9.6%, down slightly from the prior month's estimate as inflation cooled a bit.
The average age of a Fortune 500 CFO is 53, but a group of leaders became finance chiefs before their 40th birthday.
In this article, we will take a look at the top 10 gainers on Wednesday. If you want to see some more stocks moving higher today, go directly to Top 5 Gainers on Wednesday. Notable stocks from the tech and industrials sectors, including The Trade Desk, Inc. (NASDAQ:TTD), Unity Software Inc. (NYSE:U) and Plug Power […]
Four years after Siga Technologies (Nasdaq: SIGA) gained approval for a smallpox drug, the Corvallis company is gearing up to get the same antiviral into a clinical trial for monkeypox. Tpoxx, also known as tecovirimat, is the only drug available to treat the virus, though it is not yet approved in the U.S. for the disease. The Food and Drug Administration designated Tpoxx as an investigational drug for monkeypox, allowing it to be released from the Strategic National Stockpile only after prescribers jump through considerable hoops.
BHP, RIO, and GT have been added to the Zacks Rank #5 (Strong Sell) List on August 9, 2022.
(Bloomberg) -- It’s doomed, it’s a bear-market rally, a rebound that won’t last. All the mud thrown at equities over the last month may well turn out to be true. But it’s getting harder to brush aside the recovery in the S&P 500 as it hovers at a widely watched landmark in charts.Most Read from BloombergMusk Sells Another $6.9 Billion of Tesla Ahead of Twitter TrialDozens in China Infected With New ‘Langya’ Virus Carried by ShrewsUS Inflation Runs Cooler Than Forecast, Easing Pressure on FedMedi
In this article, we will look at 10 healthcare and biotech stocks to buy amid the monkeypox threat. If you want to explore similar healthcare and biotech stocks, you can also take a look at 5 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat. In May of 2022, the first case of the monkeypox […]
Yahoo Finance Live check out Plug's stock amid its earnings miss.
In this article, we discuss the 10 stocks that US Politicians are selling. If you want to read about some more stocks that US Politicians are selling, go directly to US Politicians are Selling These 5 Stocks. Recession fears in the United States stock market have been gathering pace for the past few weeks, even […]
The Dow Jones gained on inflation data. Tesla stock was up after Elon Musk made a promise. Coinbase was up amid a Bitcoin rally. Apple rose.
High fuel costs might have hurt the Q2 bottom-line performance of ZIM Integrated Shipping (ZIM).
Exela Technologies, Inc. (XELA) delivered earnings and revenue surprises of -168.33% and 7.46%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Proceed with caution on chip stocks, warns one top analyst.